Heerdt PM, Kang R, The' A, Hashim M, Mook RJ, Savarese JJ.
2004.
Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A (AV430A) in dogs.. Anesthesiology. 100(4):846-51.
Savarese JJ, Philbin DM.
1979.
Cardiovascular effects of neuromuscular blocking agents.. Int Anesthesiol Clin. 17(1):13-54.
Belmont MR, Lien CA, Quessy S, Abou-Donia MM, Abalos A, Eppich L, Savarese JJ.
1995.
The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.. Anesthesiology. 82(5):1139-45.
Basta SJ, Savarese JJ, Ali HH, Embree PB, Schwartz AF, Rudd GD, Wastila WB.
1988.
Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.. Anesthesiology. 69(4):478-86.
Belmont MR, Lien CA, Tjan J, Bradley E, Stein B, Patel SS, Savarese JJ.
2004.
Clinical pharmacology of GW280430A in humans.. Anesthesiology. 100(4):768-73.
Wastila WB, Maehr RB, Turner GL, Hill DA, Savarese JJ.
1996.
Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats.. Anesthesiology. 85(1):169-77.